- |||||||||| STP707 / Sirnaomics
Enrollment closed, Trial completion date, Trial primary completion date, Metastases: Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors (clinicaltrials.gov) - Mar 17, 2024
P1, N=50, Active, not recruiting,
Recruiting --> Active, not recruiting | Trial completion date: Sep 2024 --> Mar 2024 | Trial primary completion date: Sep 2024 --> Mar 2024
- |||||||||| STP707 / Sirnaomics
Trial completion date: A Study of STP707 Administered by IV in Healthy Subjects (clinicaltrials.gov) - May 17, 2023
P1, N=50, Active, not recruiting,
Recruiting --> Active, not recruiting | Trial completion date: Sep 2024 --> Mar 2024 | Trial primary completion date: Sep 2024 --> Mar 2024 Trial completion date: Mar 2023 --> Jun 2023
- |||||||||| STP707 / Sirnaomics
Enrollment open, Metastases: Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors (clinicaltrials.gov) - Nov 18, 2021
P1, N=40, Recruiting,
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
|
